​Ready for reliable and friendly service in a towing company? Combined with competitive rates? Call Force 1 Towing and Auto Body in Catasauqua at 610-266-6721

​Alaska Department of Health & Social Services Weekly Case Update
November 28 — December 4, 2021

Case Trends
  • Alaska currently has the thirtieth highest number of cases in the last seven days per 100,000 population among the 50 states.
  • Hospital capacity has been strained during the Delta variant wave of COVID-19 such that in some hospitals, it may become difficult to care for everyone who needs care, even for non-COVID health concerns. Some care may need to be delayed, there may be long wait times, and hospital beds may not be available.  
    • Hospitalizations are continuing to occur in younger Alaskans, with the median age of persons hospitalized due to COVID-19 in 2021 being about 5 years younger than in 2020.
    • Among those hospitalized due to COVID-19 and with specimen collection dates from January 16, 2021 through December 4, 2021, unvaccinated and partially vaccinated patients had a median age 14 years younger than fully vaccinated patients.
​
  • High levels of COVID-19 transmission are occurring throughout much of Alaska.
  • 1,624 cases were reported in Alaskans the week of November 28–December 4. This is an 18.9% decrease from the number of cases reported the week before and indicates a downward trajectory. The course of the COVID-19 pandemic is difficult to predict, and the pattern of declining cases may not be sustained in future weeks.  
  • In the five largest boroughs (Anchorage Municipality, Matanuska-Susitna Borough, Fairbanks North Star Borough, Kenai Peninsula Borough, and the City and Borough of Juneau), the number of new COVID-19 cases the week of November 28–December 4 was generally similar to the number the prior week. It is unclear if a downward trajectory is continuing. Making comparisons between weeks is difficult because the volume of testing was affected by the Thanksgiving holiday.  
  • Regardless of the trajectories, high levels of community transmission are widespread, and dozens of Alaskans are hospitalized with COVID each week.
  • The intensity of COVID-19 transmission varies substantially between communities outside the largest boroughs. COVID-19 cases are regularly reported from nearly all boroughs and census areas and some communities are experiencing extremely widespread transmission.


COVID-19 GuidanceTake action now to help slow the spread of COVID-19 and preserve health care capacity.
  • Please get vaccinated if you haven’t already and get a booster dose if you are eligible (see below for more information). Currently available COVID vaccines will help protect you, your family, and your community against COVID-19.
  • Wearing a mask when in indoor public spaces regardless of vaccination status is an important step to take to slow the spread of COVID-19. Most Alaskans live in an area with substantial or high community transmission where this action is needed to protect your health and the health of others.
  • Continue to avoid crowds and practice social distancing – particularly when indoors.
  • Seek testing if you have any symptoms or have been exposed to an infected person. If you do test positive, isolate right away, and notify your contacts. Ask them to get tested and, if they are unvaccinated, to quarantine.
  • If you test positive and you’re at increased risk for severe COVID, obtain monoclonal antibody treatment. This has been shown to be an effective treatment for reducing the risk of hospitalization. This treatment works best when given early.
  • Persons at high risk include but are not limited to persons who are elderly, immunocompromised, obese, pregnant, or have certain chronic underlying medical conditions.
Borough/Census Area Alert Level Trends
  • Alert levels are based on the case counts over the past 7 days as well as the daily number of reported cases over the past 7 days per 100,000 population.
  • Alert levels have been changed to more closely mirror CDC’s community transmission indicator and are calculated by borough and census area, rather than by region.
​Rates based on <20 observations are statistically unreliable and should be used with caution.
**Rates based on <6 observations are not reported.
Vaccination Status
  • Anyone aged ≥5 years in Alaska is now eligible to receive a COVID-19 vaccine.
  • If you have received an initial dose of the Pfizer or Moderna COVID-19 vaccine, be sure to get your second dose too.
  • Everyone ≥18 years old who received the primary series of an mRNA (Pfizer or Moderna) COVID-19 vaccine ≥6 months ago should receive a booster dose.
  • For people who received the Janssen COVID-19 vaccine, a booster dose (either the Janssen vaccine again or an mRNA vaccine) is recommended for anyone aged ≥18 years who was vaccinated ≥2 months ago.
  • Adolescents aged 16 and 17 who received the primary series of the Pfizer vaccine ≥6 months ago may receive a booster dose of the Pfizer vaccine.
  • Learn more about who should get a booster dose and to find COVID-19 vaccines near you at covidvax.alaska.gov.
  • CDC recommends that people with moderately to severely compromised immune systems receive an additional dose of mRNA COVID-19 vaccine at least 28 days after a second dose of an mRNA vaccine.
  • Vaccinated persons with immunocompromising conditions should discuss with their health care providers the need for additional personal protective measures.
  • To schedule your vaccine appointment visit covidvax.alaska.gov or call 907-646-3322.
  • To find clinics in your area you can visit vaccines.gov or text your zip code to GETVAX (438829) in English, or VACUNA (822862) for Spanish.
  • The Alaska vaccine dashboard is available online for the most up-to-date data.
Borough/Census Area Vaccination CoverageThis is the percent of Alaskans aged ≥5 years who received one or more doses of vaccine.
​New Hospitalizations and Deaths
  • Cumulative hospitalizations increased by 64 to 3,117. Hospitalization reports often lag when a case was initially reported.
  • 8.1% of hospitalized patients in Alaska had COVID-19 as of December 6, 2021.
  • On December 4th there were 75 persons with COVID-19 in AK hospitals, which is a 6.3% decrease relative to the week before when there were 80 persons hospitalized.
  • The cumulative number of COVID-19 deaths among Alaska residents increased by 5 to 853. It is common to take some time for a death to be reported and verified, and deaths that occurred during November 28–December 4 may be reported in the future after death certificates are reviewed.
Total Confirmed COVID Beds Occupied
​Variant Tracking
  • The most recent Genomic Surveillance data can be found on the “COVID-19 Variants” tab of the Cases Dashboard.
​Vaccine Breakthrough Cases
  • Vaccine breakthrough (VB) infections of COVID-19 are those detected in a person who is at least 2 weeks beyond their second dose of a 2-dose series or the only dose of a 1-dose series.
  • Alaska residents who are fully vaccinated are much less likely to be hospitalized due to COVID-19 than those who are not fully vaccinated. (Age-standardized per capita rates of COVID-19 hospitalizations by vaccination status are updated monthly.)
​
  • The following updated VB data are among Alaska residents aged ≥12 years with a specimen collection date from January 16–December 4, 2021. (Children ages 5 to 11 are not included because at this time they have not been eligible for vaccination long enough to become fully vaccinated.)
    • From January 16–December 4, 2021, 100 deaths, 310 hospitalizations, and 24,352 cases with a VB infection were reported among Alaska residents aged ≥12 years. These counts are provisional and subject to change as data are compiled and reviewed. In that same time frame, a total of 79,650 cases, 1,906 hospitalizations, and 542 deaths were reported.
    • 69% of all cases, 84% of all hospitalizations, and 82% of deaths among Alaska residents aged ≥12 years from January 16–December 4, 2021 were in people who were not fully vaccinated. 
    • More detailed information about hospitalizations, deaths, repeat and vaccine breakthrough infections among Alaska residents can also be found in the monthly report, which includes data through October.
    • Age-standardized per capita rates of COVID-19 cases by vaccination status are updated weekly. Some COVID-19 cases with specimen collection in the immediate past week (indicated by the grey box) may have not yet been reported or counted.
  • The following table shows by region the number of vaccine breakthrough cases, the number of cases among persons aged ≥12 years who are not fully vaccinated, and the number of cases among children 11 years and younger who are not fully vaccinated. (Children 5 to 11 years old have not been eligible for vaccination long enough to be considered fully vaccinated).
​To protect privacy, data are excluded from rows in which any value is <5.
  • A variety of factors may affect the proportion of vaccine breakthrough cases by region. In communities with higher vaccination coverage, a larger proportion of cases is expected to occur among fully vaccinated persons. Other potential factors include the extent of prior infection in a region and differences in testing practices between regions.
COVID-19 Communication ResourcesStatewide Percentage of Daily Tests with Positive Results
(Seven day rolling average)
​Note: Quality assurance efforts are ongoing to attribute cases to the correct date on the onset date epi curve. Some recent cases will be reattributed to different weeks.
Note: Quality assurance efforts are ongoing to attribute cases to the correct date on the onset date epi curve. Some recent cases will be reattributed to different weeks. Race abbreviations include AI/AN (American Indian or Alaska Native), Asian/NHOPI (Asian, Native Hawaiian or Other Pacific Islander), and UI/Unknown (Under investigation or unknown).
Additional informational resources:Additional ECHO session details:Updated December 9, 2021

These ECHO sessions are produced and facilitated by
UAA’s Center for Human Development Alaska ECHO project
in partnership with the State of Alaska, Department of Health & Social ServicesSession information and recordings of previous ECHO sessions
subscribe to ECHO calendar updates | email: [email protected] | website: akecho.org
Important Note: Most Division of Public Health ECHO series will be taking a break from December 20-December 31 for the winter holidays. Please check individual ECHO registration pages for additional information on holiday scheduling.
Our Alaska Medical Providers ECHO is returning to a once-monthly schedule, on the 1st Tuesday of the month. The next session will take place Tuesday, December 7. Visit the series registration page for additional information.
Regular SeriesAlaska Medical Provider ECHO (formerly COVID-19 for AK Healthcare Providers)
Monthly on the 1st Tuesday of the month from 7-8 pm
This ECHO aims to increase knowledge and share best practices among medical providers across Alaska as well as to increase access to information for those living in rural areas of the state.
School Health ECHO
Every Monday from 3:00-4:00 p.m Register
The School Health ECHO is a virtual learning network intended for professionals in the education setting (administrators, school-based nurses, etc.) to interface with a team of medical and education experts in Alaska.
Vaccine ECHO for Providers
Weekly on Tuesday from 2-3 p.m. Register
The Vaccine ECHO for providers provides planning and operation updates to vaccine providers across Alaska, while answering any questions you may have.
Palliative Care ECHO
Monthly on the first Tuesday from 12-1 p.m.
This monthly ECHO is for all Alaskan healthcare disciplines supporting patients with serious illness, and aims to provide support and up-to-date information regarding Palliative Care during this period of COVID-19.
Public Science ECHO
Weekly on Wednesday from 12-1 p.m. register via Zoom
The Alaska Public Health Science ECHO is a virtual learning network intended for the general public to interface with our Public Health Leadership Team to explore the science of the COVID-19 virus, other public health topics, and current best practices. Or view via concurrent livestream to Facebook: https://www.facebook.com/akechoprograms
Local Government Public Health ECHO
Monthly on the third Wednesday from 3-4 p.m. Register
The Local Government Public Health Analysis ECHO is a virtual learning environment intended for local Alaska government leaders to interact with the State Public Health Leadership team and focuses on pandemic mitigation tools available, and how to use them.
Long Term Care Facilities ECHO 
Second Wednesday of the month from 4-5 p.m. Register 
Please join other staff and administrators of Alaska’s assisted living homes and residential care facilities to gather, learn, share, and grow. COVID has disrupted the fabric of our daily life and we can always learn from each other as we adjust to the new normal.
Healthcare Specific Situational Awareness ECHO
Weekly on Thursday from 12-1 p.m.  Register
The Healthcare Specific Situational ECHO is a virtual learning network intended for healthcare professionals to interface with our Public Health Leadership Team to explore current best practices and the most recent information related to Public Health.
Perinatal ECHO
Monthly on 3rd Thursday from 6-7 p.m. Register
The Alaska Perinatal ECHO is a virtual learning network intended for medical providers caring for pregnant patients and their newborns.
EMS ECHO
Monthly on the 1st and 3rd Wednesday 1-2 p.m Register
The EMS ECHO is a virtual learning network intended for Emergency Medical Services and related personnel in Alaska to amplify best practices. Sessions are topic-driven and typically include a guest presenter or a brief lecture with an interactive case or process discussion.
Co-Occurring Behavioral Health, Opioid and Stimulant Use Disorders ECHO
1st & 3rd Wednesdays from 12:00pm-1:00pm, November 3, 2021 - April 20, 2022
The Co-Occurring Behavioral Health (COBH), Opioid and Stimulant Use Disorders ECHO facilitates a virtual network for behavioral health providers to learn best practice care through real-time access to experienced subject matter experts and their peers. Each session includes a brief lecture, de-identified case presentation for participants to receive feedback on complex cases, and open discussion facilitated by an interdisciplinary team.
Data Waivers ECHO New ECHO!
2nd Wednesdays from 12:00pm-1:00pm, November 10, 2021 - September 14, 2022
The Data Waivers ECHO facilitates a virtual network for clinical providers to learn and implement best practices for offering buprenorphine and other medically assisted treatment (MAT) services under a data waiver. Each session includes a brief lecture, de-identified case presentation for participants to receive feedback on complex cases, and open discussion facilitated by an interdisciplinary team.